JPWO2023022200A1 - - Google Patents
Info
- Publication number
- JPWO2023022200A1 JPWO2023022200A1 JP2023542442A JP2023542442A JPWO2023022200A1 JP WO2023022200 A1 JPWO2023022200 A1 JP WO2023022200A1 JP 2023542442 A JP2023542442 A JP 2023542442A JP 2023542442 A JP2023542442 A JP 2023542442A JP WO2023022200 A1 JPWO2023022200 A1 JP WO2023022200A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234305P | 2021-08-18 | 2021-08-18 | |
| PCT/JP2022/031229 WO2023022200A1 (ja) | 2021-08-18 | 2022-08-18 | 免疫チェックポイント阻害剤に対する応答性の予測用バイオマーカー |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023022200A1 true JPWO2023022200A1 (https=) | 2023-02-23 |
Family
ID=85240815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542442A Pending JPWO2023022200A1 (https=) | 2021-08-18 | 2022-08-18 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20240241130A1 (https=) |
| JP (1) | JPWO2023022200A1 (https=) |
| WO (1) | WO2023022200A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2017142394A (ru) * | 2015-05-08 | 2019-06-10 | Президент Энд Феллоус Оф Гарвард Колледж | Целевой отбор пациентов для лечения производными кортистатина |
| WO2018225063A1 (en) * | 2017-06-04 | 2018-12-13 | Rappaport Family Institute For Research In The Medical Sciences | Method of predicting personalized response to cancer treatment with immune checkpoint inhibitors and kits therefor |
| CA3066918A1 (en) * | 2017-06-12 | 2018-12-20 | Bluefin Biomedicine, Inc. | Anti-il1rap antibodies and antibody drug conjugates |
| US11428691B2 (en) * | 2018-01-23 | 2022-08-30 | Duke University | Methods for predicting tumor response to immunotherapy |
-
2022
- 2022-08-18 JP JP2023542442A patent/JPWO2023022200A1/ja active Pending
- 2022-08-18 WO PCT/JP2022/031229 patent/WO2023022200A1/ja not_active Ceased
- 2022-08-18 US US18/684,272 patent/US20240241130A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240241130A1 (en) | 2024-07-18 |
| WO2023022200A1 (ja) | 2023-02-23 |